Literature DB >> 10984637

Estrogen, progestogen and tamoxifen increase synaptic density of the hippocampus of ovariectomized rats.

I Silva1, L E Mello, E Freymüller, M A Haidar, E C Baracat.   

Abstract

The effects of gonadal steroids or tamoxifen over the synaptic density of the CA1 region of the hippocampus was investigated in ovariectomized (OVX) rats. Chronic oral administration of conjugated equine estrogen, conjugated equine medroxyprogesterone, a combination of both or tamoxifen was performed in ovariectomized (OVX) rats over a period of 60 days. Synaptic density of the stratum radiatum of the CA1 region was evaluated by means of electron microscopy. Significant increases in the range of 34-49% were found for treated animals as compared to OVX controls not subject to hormonal replacement. Our results confirm previously reported effects of estradiol over synaptic density in this region and reports for the first time an effect of medroxyprogesterone (alone or in combination with estrogen) and tamoxifen. Our findings support the notion that hormonal replacement therapy and tamoxifen might have beneficial effects for cognitive function.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10984637     DOI: 10.1016/s0304-3940(00)01410-5

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  19 in total

Review 1.  Estrogenic modulation of brain activity: implications for schizophrenia and Parkinson's disease.

Authors:  Michel Cyr; Frederic Calon; Marc Morissette; Thérèse Di Paolo
Journal:  J Psychiatry Neurosci       Date:  2002-01       Impact factor: 6.186

2.  L-3-n-butylphthalide Rescues Hippocampal Synaptic Failure and Attenuates Neuropathology in Aged APP/PS1 Mouse Model of Alzheimer's Disease.

Authors:  Yu Zhang; Long-Jian Huang; Si Shi; Shao-Feng Xu; Xiao-Liang Wang; Ying Peng
Journal:  CNS Neurosci Ther       Date:  2016-07-20       Impact factor: 5.243

3.  Chronic stress and a cyclic regimen of estradiol administration separately facilitate spatial memory: relationship with hippocampal CA1 spine density and dendritic complexity.

Authors:  Cheryl D Conrad; Katie J McLaughlin; Thu N Huynh; Mariam El-Ashmawy; Michelle Sparks
Journal:  Behav Neurosci       Date:  2011-10-17       Impact factor: 1.912

Review 4.  Protective actions of sex steroid hormones in Alzheimer's disease.

Authors:  Christian J Pike; Jenna C Carroll; Emily R Rosario; Anna M Barron
Journal:  Front Neuroendocrinol       Date:  2009-05-07       Impact factor: 8.606

5.  Effects of long-term treatment with estrogen and medroxyprogesterone acetate on synapse number in the medial prefrontal cortex of aged female rats.

Authors:  Nioka C Chisholm; Janice M Juraska
Journal:  Menopause       Date:  2012-07       Impact factor: 2.953

Review 6.  Cognitive effects of endocrine therapy for breast cancer: keep calm and carry on?

Authors:  Wilbert Zwart; Huub Terra; Sabine C Linn; Sanne B Schagen
Journal:  Nat Rev Clin Oncol       Date:  2015-07-21       Impact factor: 66.675

7.  Conjugated equine estrogen, with medroxyprogesterone acetate, enhances formation of 5alpha-reduced progestogens and reduces anxiety-like behavior of middle-aged rats.

Authors:  Cheryl A Frye; Alicia A Walf; Jason J Paris
Journal:  Behav Pharmacol       Date:  2010-09       Impact factor: 2.293

8.  Effects of long-term treatment with 17 beta-estradiol and medroxyprogesterone acetate on water maze performance in middle aged female rats.

Authors:  Nioka C Lowry; Laura P Pardon; Melissa A Yates; Janice M Juraska
Journal:  Horm Behav       Date:  2010-04-01       Impact factor: 3.587

Review 9.  Neuropsychiatric effects of tamoxifen: Challenges and opportunities.

Authors:  Andrew M Novick; Anthony T Scott; C Neill Epperson; Christopher D Schneck
Journal:  Front Neuroendocrinol       Date:  2020-08-18       Impact factor: 8.606

Review 10.  Estrogen and selective estrogen receptor modulators: neuroprotection in the Women's Health Initiative era.

Authors:  Stephanie Murphy; Louise McCullough; Marguerite Littleton-Kearney; Patricia Hurn
Journal:  Endocrine       Date:  2003-06       Impact factor: 3.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.